NasdaqHealth CareHealth Care EquipmentS&P MidCap 400
$89.99
-1.15 (-1.26%)
Close of Nov 06, 2026 · end-of-day data
Source: LivaNova's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026
Revenue, net income & free cash flow
Income statement
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
$964.86M
$1.01B
$1.11B
$1.08B
$934.24M
$1.04B
$1.02B
$1.15B
$1.25B
$1.39B
Cost of revenue
$367.85M
$353.19M
$361.32M
$360.37M
$339.48M
$329.37M
$314.58M
$397.73M
$399.95M
$448.18M
Gross profit
$559.51M
$651.62M
$745.64M
$723.80M
$594.76M
$705.99M
$707.23M
$755.82M
$853.48M
$939.87M
Research & development
$82.08M
$109.52M
$145.95M
$146.85M
$152.90M
$183.41M
$155.81M
$193.82M
$182.51M
$185.76M
Selling, general & admin
$355.16M
$380.10M
$464.97M
$528.47M
$446.56M
$471.90M
$469.24M
$502.70M
$508.88M
$548.81M
Operating income
$33.45M
$96.49M
-$248.07M
-$171.55M
-$273.90M
-$784.00K
-$76.75M
-$68.50M
$129.05M
$199.39M
Interest expense
$10.62M
$7.80M
$9.82M
$15.09M
$40.84M
$50.15M
$48.25M
$58.85M
$63.07M
$49.29M
Pre-tax income
$25.67M
$121.14M
-$247.45M
-$188.38M
-$348.02M
-$124.47M
-$75.14M
-$81.23M
$88.31M
-$220.78M
Income tax
$5.11M
$49.95M
-$69.63M
-$30.37M
-$960.00K
$11.20M
$11.05M
-$98.88M
$25.06M
$21.64M
Net income
-$62.79M
-$25.09M
-$189.40M
-$157.64M
-$348.82M
-$135.82M
-$86.25M
$17.55M
$63.23M
-$242.47M
EBITDA
$118.81M
$133.54M
-$215.33M
-$141.24M
-$244.87M
$23.75M
-$54.38M
-$43.76M
$154.16M
$227.95M
EPS (basic)
$-1.29
$-0.52
$-3.91
$-3.21
$-7.18
$-2.68
$-1.61
$0.33
$1.17
$-4.45
EPS (diluted)
$-1.28
$-0.52
$-3.91
$-3.26
$-7.18
$-2.68
$-1.61
$0.32
$1.16
$-4.45
Diluted shares
49.01M
48.50M
48.50M
48.35M
48.59M
50.63M
53.47M
54.21M
54.57M
54.55M
Gross margin
58.0%
64.4%
67.4%
66.8%
63.7%
68.2%
69.2%
65.5%
68.1%
67.7%
Operating margin
3.5%
9.5%
-22.4%
-15.8%
-29.3%
-0.1%
-7.5%
-5.9%
10.3%
14.4%
Net margin
-6.5%
-2.5%
-17.1%
-14.5%
-37.3%
-13.1%
-8.4%
1.5%
5.0%
-17.5%
Balance sheet
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash & equivalents
$39.79M
$93.61M
$47.20M
$61.14M
$252.83M
$207.99M
$214.17M
$266.50M
$428.86M
$635.55M
Receivables
$213.26M
$282.14M
$256.13M
$257.77M
$184.36M
$185.35M
$183.11M
$215.07M
$193.16M
$215.99M
Inventory
$133.02M
$144.47M
$153.53M
$164.15M
$115.28M
$105.84M
$129.38M
$147.89M
$147.57M
$164.70M
Total current assets
$812.69M
$869.86M
$533.30M
$549.44M
$708.04M
$679.18M
$886.14M
$988.16M
$1.13B
$1.10B
Goodwill
$691.71M
$784.24M
$956.82M
$915.79M
$922.32M
$899.52M
$768.79M
$782.94M
$750.01M
$792.84M
Total assets
$2.34B
$2.50B
$2.55B
$2.41B
$2.40B
$2.20B
$2.29B
$2.43B
$2.51B
$2.61B
Total current liabilities
$349.89M
$406.02M
$496.75M
$512.55M
$309.05M
$696.97M
$297.40M
$334.98M
$392.12M
$808.07M
Short-term debt
$47.65M
$84.03M
$28.79M
$77.40M
$13.34M
$229.67M
$23.43M
$18.11M
$78.00M
$31.47M
Long-term debt
$75.22M
$61.96M
$139.54M
$260.33M
$642.30M
$9.85M
$518.07M
$568.54M
$549.62M
$345.19M
Total debt
$122.86M
$145.99M
$168.33M
$337.73M
$655.64M
$239.52M
$541.50M
$586.65M
$627.63M
$376.66M
Total liabilities
$635.72M
$688.58M
$1.05B
$1.03B
$1.29B
$906.31M
$1.09B
$1.15B
$1.19B
$1.41B
Shareholders' equity
$1.71B
$1.82B
$1.50B
$1.38B
$1.11B
$1.29B
$1.21B
$1.28B
$1.32B
$1.20B
Cash flow
fiscal years · USD
Fiscal year
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Operating cash flow
$90.15M
$91.34M
$120.49M
-$91.14M
-$79.42M
$102.54M
$69.92M
$74.91M
$183.04M
$254.34M
Capital expenditures
$38.36M
$32.93M
$37.19M
$24.69M
$35.02M
$25.48M
$26.52M
$34.98M
$47.11M
$81.05M
Free cash flow
$51.79M
$58.41M
$83.30M
-$115.83M
-$114.45M
$77.07M
$43.40M
$39.93M
$135.93M
$173.29M
Investing cash flow
-$44.52M
-$52.85M
-$120.56M
-$41.29M
-$41.84M
$36.90M
-$38.41M
-$40.33M
-$48.16M
-$72.91M
Financing cash flow
-$118.04M
$11.29M
-$42.35M
$146.58M
$310.76M
-$181.48M
$280.13M
$21.48M
$18.55M
-$285.66M
Share buybacks
$54.49M
$0
$50.00M
$0
$0
—
—
—
—
—
Stock-based compensation
$19.57M
$19.06M
$26.92M
$32.55M
$35.09M
$40.56M
$44.81M
$36.35M
$33.93M
$36.29M
Depreciation & amortization
$85.36M
$37.05M
$32.75M
$30.32M
$29.03M
$24.54M
$22.37M
$24.74M
$25.10M
$28.56M
Income statement
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
$310.13M
$294.91M
$318.57M
$318.12M
$321.83M
$316.86M
$352.52M
$357.75M
$360.92M
$362.26M
$390.59M
$393.15M
Cost of revenue
$135.40M
$91.70M
$103.70M
$97.09M
$107.46M
$100.60M
$113.54M
$112.90M
$121.15M
$118.51M
$116.92M
$128.10M
Gross profit
$174.74M
$203.21M
$214.88M
$221.03M
$214.37M
$216.25M
$238.99M
$244.85M
$239.77M
$243.75M
$273.67M
$265.05M
Research & development
$46.17M
$45.66M
$44.74M
$48.80M
$43.31M
$37.88M
$47.19M
$48.58M
$52.12M
$58.70M
$53.66M
$47.69M
Selling, general & admin
$117.90M
$125.68M
$125.13M
$127.43M
$130.64M
$129.15M
$137.78M
$138.52M
$143.37M
$143.57M
$158.13M
$154.93M
Operating income
-$87.99M
$16.25M
$40.17M
$35.62M
$37.02M
$48.62M
$54.18M
$54.01M
$42.58M
$41.47M
$49.48M
$28.43M
Interest expense
$15.62M
$15.89M
$15.53M
$15.88M
$15.77M
$15.29M
$14.93M
$10.86M
$8.21M
$8.29M
$7.18M
$7.95M
Pre-tax income
-$94.30M
-$34.20M
$21.59M
$44.44M
$56.48M
-$315.65M
$33.32M
$33.91M
$27.63M
$27.48M
$18.48M
$46.77M
Income tax
-$110.65M
$7.72M
$5.23M
$11.53M
$589.00K
$11.66M
$6.15M
$7.11M
-$3.28M
$4.34M
-$90.20M
$12.40M
Net income
$16.34M
-$41.94M
$16.33M
$32.95M
$55.89M
-$327.32M
$27.16M
$26.78M
$30.91M
$22.29M
$108.57M
$34.29M
EBITDA
-$81.83M
$22.51M
$46.34M
$41.86M
$43.44M
$55.04M
$61.06M
$61.73M
$50.13M
$49.77M
$58.24M
$37.53M
EPS (basic)
$0.31
$-0.78
$0.30
$0.61
$1.03
$-6.01
$0.50
$0.49
$0.56
$0.41
$1.98
$0.62
EPS (diluted)
$0.30
$-0.78
$0.30
$0.60
$1.03
$-6.01
$0.50
$0.49
$0.56
$0.40
$1.93
$0.11
Diluted shares
105.00K
54.01M
54.59M
54.59M
48.00K
54.42M
54.71M
55.15M
19.00K
55.94M
56.27M
57.37M
Gross margin
56.3%
68.9%
67.4%
69.5%
66.6%
68.3%
67.8%
68.4%
66.4%
67.3%
70.1%
67.4%
Operating margin
-28.4%
5.5%
12.6%
11.2%
11.5%
15.3%
15.4%
15.1%
11.8%
11.4%
12.7%
7.2%
Net margin
5.3%
-14.2%
5.1%
10.4%
17.4%
-103.3%
7.7%
7.5%
8.6%
6.2%
27.8%
8.7%
Balance sheet
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Cash & equivalents
$266.50M
$309.19M
$329.24M
$346.37M
$428.86M
$738.44M
$593.64M
$646.08M
$635.55M
$539.71M
$516.62M
$563.47M
Receivables
$215.07M
$209.43M
$200.89M
$197.16M
$193.16M
$202.08M
$220.19M
$211.58M
$215.99M
$229.27M
$231.30M
$236.37M
Inventory
$147.89M
$153.18M
$154.72M
$162.26M
$147.57M
$154.02M
$165.35M
$167.54M
$164.70M
$165.50M
$172.61M
$177.88M
Total current assets
$988.16M
$1.04B
$1.05B
$1.09B
$1.13B
$1.17B
$1.07B
$1.10B
$1.10B
$1.01B
$1.03B
$1.08B
Goodwill
$782.94M
$771.82M
$766.37M
$781.55M
$750.01M
$761.91M
$793.37M
$791.03M
$792.84M
$785.59M
$779.14M
$778.80M
Total assets
$2.43B
$2.46B
$2.45B
$2.52B
$2.51B
$2.56B
$2.51B
$2.56B
$2.61B
$2.52B
$2.64B
$2.71B
Total current liabilities
$334.98M
$327.77M
$302.99M
$324.40M
$392.12M
$741.57M
$827.10M
$827.59M
$808.07M
$762.48M
$707.00M
$740.19M
Short-term debt
$18.11M
$19.70M
$19.74M
$21.95M
$78.00M
$79.57M
$82.13M
$85.44M
$31.47M
$2.63M
$3.58M
$3.90M
Long-term debt
$568.54M
$604.75M
$605.43M
$604.29M
$549.62M
$549.22M
$348.49M
$349.03M
$345.19M
$285.16M
$289.91M
$295.19M
Total debt
$586.65M
$624.46M
$625.17M
$626.24M
$627.63M
$628.79M
$430.62M
$434.47M
$376.66M
$287.79M
$293.49M
$299.09M
Total liabilities
$1.15B
$1.24B
$1.21B
$1.21B
$1.19B
$1.52B
$1.38B
$1.40B
$1.41B
$1.31B
$1.32B
$1.34B
Shareholders' equity
$1.28B
$1.22B
$1.24B
$1.31B
$1.32B
$1.03B
$1.12B
$1.16B
$1.20B
$1.21B
$1.33B
$1.37B
Cash flow
quarters · USD
Quarter ended
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Operating cash flow
$53.96M
$9.98M
$43.36M
$50.99M
$78.71M
$23.97M
$62.92M
$85.06M
$82.40M
$15.22M
$66.59M
$73.66M
Capital expenditures
$12.92M
$6.40M
$12.16M
$18.15M
$10.41M
$10.79M
$15.15M
$22.88M
$32.23M
$14.29M
$31.55M
$30.77M
Free cash flow
$41.04M
$3.58M
$31.20M
$32.85M
$68.30M
$13.18M
$47.77M
$62.18M
$50.16M
$926.00K
$35.04M
$42.89M
Investing cash flow
-$12.14M
-$6.36M
-$12.57M
-$18.52M
-$10.71M
-$10.63M
-$8.97M
-$23.06M
-$30.26M
-$14.58M
-$31.92M
-$23.11M
Financing cash flow
-$5.02M
$37.15M
-$11.87M
-$3.28M
-$3.44M
-$4.42M
-$208.98M
-$9.37M
-$62.88M
-$94.25M
-$56.45M
-$2.92M
Stock-based compensation
$8.28M
$10.23M
$8.20M
$8.56M
$6.95M
$7.78M
$9.17M
$9.95M
$9.39M
$8.27M
$16.88M
$14.55M
Depreciation & amortization
$6.16M
$6.27M
$6.17M
$6.24M
$6.42M
$6.42M
$6.87M
$7.71M
$7.55M
$8.30M
$8.75M
$9.10M
Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.